[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fcj9ayEbKDr8XRH60Y0osWA6_SlsEsl5P_2GuChkvyys":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":34,"rows":41},"University Children's Hospital, Zurich",[4],91,false,20,1,22859,0,86,[14,17,19,22,24,26,29,31],{"name":15,"count":16},"Cerebral Palsy",5,{"name":18,"count":16},"Congenital Heart Disease",{"name":20,"count":21},"Stroke",3,{"name":23,"count":21},"Traumatic Brain Injury",{"name":25,"count":21},"Meningomyelocele",{"name":27,"count":28},"Type 1 Diabetes",2,{"name":30,"count":28},"Quality of Life",{"name":32,"count":28},"Epilepsy",[],[35,36,37,38,39,40],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[42,69,95,123,141,167],{"intervention":43,"totalTrials":9,"cells":44},"intravenous injection of test solution",{"EARLY_PHASE1":45,"PHASE1":47,"PHASE2":49,"PHASE3":51,"PHASE4":53,"NA":67},{"trials":46,"activeCount":11},[],{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[55],{"nctId":56,"briefTitle":57,"status":58,"phases":59,"primaryCompletion":60,"completion":60,"start":61,"enrollment":62,"conditions":63,"interventions":66},"NCT01091766","Sensitivity of ECG on Detection of Three Different Intravascular Applied Test Doses of Bupivacaine and Epinephrine","COMPLETED",[39],"2011-07","2010-03",150,[64,65],"Anaesthesia","Toxicity",[43,43,43],{"trials":68,"activeCount":11},[],{"intervention":70,"totalTrials":9,"cells":71},"Human fibrinogen concentrate",{"EARLY_PHASE1":72,"PHASE1":74,"PHASE2":76,"PHASE3":78,"PHASE4":80,"NA":93},{"trials":73,"activeCount":11},[],{"trials":75,"activeCount":11},[],{"trials":77,"activeCount":11},[],{"trials":79,"activeCount":11},[],{"trials":81,"activeCount":11},[82],{"nctId":83,"briefTitle":84,"status":58,"phases":85,"primaryCompletion":86,"completion":86,"start":87,"enrollment":88,"conditions":89,"interventions":92},"NCT01487837","Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.",[39],"2014-10","2012-01",57,[90,91],"Blood Coagulation Disorders","Hemorrhage",[70],{"trials":94,"activeCount":11},[],{"intervention":96,"totalTrials":9,"cells":97},"Fentanyl intranasal",{"EARLY_PHASE1":98,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":119,"NA":121},{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[],{"trials":103,"activeCount":11},[],{"trials":105,"activeCount":11},[106],{"nctId":107,"briefTitle":108,"status":58,"phases":109,"primaryCompletion":110,"completion":110,"start":111,"enrollment":112,"conditions":113,"interventions":117},"NCT02533908","Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children",[38],"2017-10-12","2015-09-21",402,[114,115,116],"Inhalation of Nitrous Oxide","Opioid Analgesic Adverse Reaction","Pain",[96,118],"NaCl 0.9% intranasal",{"trials":120,"activeCount":11},[],{"trials":122,"activeCount":11},[],{"intervention":118,"totalTrials":9,"cells":124},{"EARLY_PHASE1":125,"PHASE1":127,"PHASE2":129,"PHASE3":131,"PHASE4":137,"NA":139},{"trials":126,"activeCount":11},[],{"trials":128,"activeCount":11},[],{"trials":130,"activeCount":11},[],{"trials":132,"activeCount":11},[133],{"nctId":107,"briefTitle":108,"status":58,"phases":134,"primaryCompletion":110,"completion":110,"start":111,"enrollment":112,"conditions":135,"interventions":136},[38],[114,115,116],[96,118],{"trials":138,"activeCount":11},[],{"trials":140,"activeCount":11},[],{"intervention":142,"totalTrials":9,"cells":143},"Nalbuphine",{"EARLY_PHASE1":144,"PHASE1":146,"PHASE2":159,"PHASE3":161,"PHASE4":163,"NA":165},{"trials":145,"activeCount":11},[],{"trials":147,"activeCount":11},[148],{"nctId":149,"briefTitle":150,"status":151,"phases":152,"primaryCompletion":153,"completion":153,"start":154,"enrollment":155,"conditions":156,"interventions":158},"NCT03059511","Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants","TERMINATED",[36],"2018-01-10","2017-03-03",51,[157],"Pharmacokinetic",[142],{"trials":160,"activeCount":11},[],{"trials":162,"activeCount":11},[],{"trials":164,"activeCount":11},[],{"trials":166,"activeCount":11},[],{"intervention":168,"totalTrials":9,"cells":169},"a caudal block",{"EARLY_PHASE1":170,"PHASE1":172,"PHASE2":174,"PHASE3":176,"PHASE4":178,"NA":180},{"trials":171,"activeCount":11},[],{"trials":173,"activeCount":11},[],{"trials":175,"activeCount":11},[],{"trials":177,"activeCount":11},[],{"trials":179,"activeCount":11},[],{"trials":181,"activeCount":11},[182],{"nctId":183,"briefTitle":184,"status":58,"phases":185,"primaryCompletion":186,"completion":187,"start":188,"enrollment":189,"conditions":190,"interventions":192},"NCT02339298","Intraoperative Music Application and Postoperative Behaviour in Children and Adolescents.",[40],"2015-10","2015-11","2009-07",140,[191],"Postoperative Behaviour",[168]]